News for p2
August 24, 2018
DL: 14 November 2018 - SECURE SOCIETIES- protecting freedom and security of Europe and its citizens call for proposals 2018 is opened. The core of research in this area is the development of new products to meet the needs of security practitioners. Research is not just about developing...Click to know more
October 06, 2020
Targeting our second brain to fight diabetes
Patrice Cani (UCLouvain) and Claude Knauf (INSERM) have discovered a ‘jammer’ that blocks communication between the gut and the brain, thus preventing proper regulation of sugar and causing insulin resistance in people with diabetes. They also discovered that a lipid produced...Click to know more
September 11, 2020
New immunotherapy to beat cancer
Sophie Lucas (UCLouvain de Duve Institute) and her team succeeded in neutralising a molecule that blocks the immune system against cancer. UCLouvain scientists discovered that this new immunotherapy increases the action of another well-known but not always effective...Click to know more
July 01, 2020
VIVES III: a new European inter-university fund of...
The UCLouvain created, through its technology transfer office Sopartec, a new European university fund of €32m, VIVES Inter-University Fund. Its ambition? Accelerate the transformation of research into a societal benefit. The fund offers a unique ecosystem with incubators and...Click to know more
June 22, 2020
Click… Resistant bacteria caught in the act !
As humanity fights against the coronavirus, the battle against antibiotic resistant bacteria continues. Scientists at UCLouvain have succeeded in capturing unique images of protein soldiers that help bacteria resist drugs. This discovery is published in the prestigious scientific...Click to know more